Candesartan-d4

• CAT Number: S000053
• CAS Number: 1346604-70-3
• Molecular Formula: C24H16D4N6O3
• Molecular Weight: 444.48
• Purity: ≥95%
• Target: Angiotensin Receptor
• IUPAC Name: 2-ethoxy-3-[[2,3,5,6-tetradeuterio-4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid
• InChI: InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)/i10D,11D,12D,13D
• InChIKey: HTQMVQVXFRQIKW-ZGAVCIBUSA-N
• SMILES: [2H]C1=C(C(=C(C(=C1CN2C3=C(C=CC=C3N=C2OCC)C(=O)O)[2H])[2H])C4=CC=CC=C4C5=NNN=N5)[2H]

Candesartan-d4 (CAS 1346604-70-3) is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Candesartan is essential for studies involving angiotensin II receptor antagonists, hypertension treatment, pharmacokinetics, and metabolic pathways. Featuring four deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for cardiovascular research and drug development, Candesartan-d4 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.